Protocol B: Low Maintenance (0.25 mg indefinite) This is the most conservative approach and stays within studied dose ranges during the taper
2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla 90110, Thailand *These authors contributed equally to this work Correspondence: Ramzi A Ajjan Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire LS2 9JT, UK Tel +44 113 343 7475 Email [email protected] Abstract: In recent years, newer drug classes for the treatment of type 2 diabetes mellitus have been released with significant effects on glucose lowering and weight reduction
[2] [3] For medicines like warfarin, the MHRA product information recommends monitoring INR when initiating semaglutide treatment
Before starting treatment, discuss your medical history and current medications with your healthcare provider
